Zarontin Related Published Studies
Research related to Zarontin (Ethosuximide)
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy. [2008.08]
Is ethosuximide a risk factor for generalised tonic-clonic seizures in absence epilepsy? [2007.04]
Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis. [2006.11]
Evaluation of gabapentin and ethosuximide for treatment of acute nonconvulsive seizures following ischemic brain injury in rats. [2006.09]
7-Nitroindazole enhances dose-dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. [2006.09]
The effects of ethosuximide on amino acids in genetic absence epilepsy rat model. [2006.03]
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. [2005.10.19]
A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine. [2005.03]
Other possibly related research studies
Involvement of dorsolateral periaqueductal gray N-methyl-D-aspartic acid glutamate receptors in the regulation of risk assessment and inhibitory avoidance behaviors in the rat elevated T-maze. [2006.11]
Levetiracetam-induced myoclonic status epilepticus in myoclonic-astatic epilepsy: a case report. [2006.09]
Effects of anticonvulsant drugs on life span. [2006.04]
Influence of cimetidine on the anticonvulsant activity of conventional antiepileptic drugs against pentetrazole-induced seizures in mice. [2006.01]
Pharmacologic evidence for abnormal thalamocortical functioning in GABA receptor beta3 subunit-deficient mice, a model of Angelman syndrome. [2005.12]
Motor impairment on awakening in a patient with an EEG pattern of "unilateral, continuous spikes and waves during slow sleep". [2005.06]
Development of a new genetic model for absence epilepsy: spike-wave seizures in C3H/He and backcross mice. [2005.03.30]
Anticonvulsant medications extend worm life-span. [2005.01.14]
A magnetoencephalographic study of negative myoclonus in a patient with atypical benign partial epilepsy. [2005.01]
Epilepsy with myoclonic absences. [2006]
Differences between prescribed daily doses and defined daily doses of antiepileptics--therapeutic drug monitoring as a marker of the quality of the treatment. [2006.09]
Diagnostic issues and treatment of cryptogenic or symptomatic generalized epilepsies. [2006.08]
Role of valproate across the ages. Treatment of epilepsy in children. [2006]
[Carbamazepine-induced systemic lupus erythematosus--a case report] [2006.03]
Treatment of pediatric epilepsy: expert opinion, 2005. [2005.12]
Valproate as a mainstay of therapy for pediatric epilepsy. [2006]
Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents. [2006.03]
Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders. [2006.06]
Management of Landau-Kleffner syndrome. [2005]
Evidence-based treatment of idiopathic generalized epilepsies with older antiepileptic drugs. [2005]
Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies. [2005]
Best practice guidelines for the management of women with epilepsy. [2005]
Photosensitivity in idiopathic generalized epilepsies. [2005]
Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively. [2005.10]
Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats. [2005.09.28]
Antiepileptic drug monotherapy: pediatric concerns. [2005.06]
Treatment of epilepsy in adults: expert opinion, 2005. [2005.09]
Ion channels and epilepsy. [2005]
Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats. [2005.06]
Bupropion-induced convulsions: preclinical evaluation of antiepileptic drugs. [2005.03]
Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats. [2005.06]
Epilepsy with myoclonic absences. [2005.04]
Effect of antiepileptic drug polytherapy on crystalluria. [2005.02]
Mechanisms of action of antiepileptic drugs. [2005]
Sleep-related epilepsy in the A/J mouse. [2007.02.01]
7-12 Hz high-voltage rhythmic spike discharges in rats evaluated by antiepileptic drugs and flicker stimulation. [2007.01]
Prophylactic and therapeutic functions of T-type calcium blockers against noise-induced hearing loss. [2007.04]
Evaluation of anticonvulsant and analgesic effects of benzyl- and benzhydryl ureides. [2007.03.22]
Effect of antiepileptic drugs on spontaneous seizures in epileptic rats. [2007.02]
Juvenile myoclonic epilepsy: a benign disorder? Personality traits and psychiatric symptoms. [2007.06]
Negative myoclonus. An overview of its clinical features, pathophysiological mechanisms, and management. [2006.09]
Conventional anticonvulsant drugs in the guinea-pig kindling model of partial seizures: effects of repeated administration. [2007.03]
Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia. [2007.09]
Levetiracetam attenuates spontaneous spike-and-wave discharges in DBA/2J mice. [2007.07]
Beneficial effects of antiepileptic medication on absence seizures and cognitive functioning in children. [2007.08]
Effects of certain antiepileptics on behavioral and electromyographic seizure patterns induced by maximal electroshock in mice. [2007.05]
Thalidomide inhibits pentylenetetrazole-induced seizures. [2007.07.15]
Negative effects of antiepileptic drugs on mood in patients with epilepsy. [2007]
Antiepileptic drugs and visual function. [2007.06]
Treatment of pediatric epilepsy: European expert opinion, 2007. [2007.12]
Analysis and mapping of CACNB4, CHRNA1, KCNJ3, SCN2A and SPG4, physiological candidate genes for porcine congenital progressive ataxia and spastic paresis. [2007.10]
T-current related effects of antiepileptic drugs and a Ca2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy. [2007.09]
Absence epilepsy in childhood: electroencephalography (EEG) does not predict outcome. [2007.07]
Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice. [2007.10]
Childhood absence epilepsy with clinically apparent genetic and acquired burdens: a diagnostic consideration. [2008.01]
Effects of various antiepileptics on behavioral and electroencephalographic seizures induced by maximal electroshock in mice. [2008.01]
Inhibition of human aromatase complex (CYP19) by antiepileptic drugs. [2008.02]
Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety. [2007.10]
Early treatment suppresses the development of spike-wave epilepsy in a rat model. [2008.03]
Drug interactions between chemotherapeutic regimens and antiepileptics. [2008.08]
Epileptogenic activity induced by teicoplanin and effects of some antiepileptics in mice. [2008.08]
The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models. [2008.07]
|
